Jpmorgan Chase & CO Twist Bioscience Corp Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Twist Bioscience Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,452,108 shares of TWST stock, worth $43.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,452,108
Previous 1,799,212
19.29%
Holding current value
$43.8 Million
Previous $83.6 Million
31.81%
% of portfolio
0.0%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding TWST
# of Institutions
266Shares Held
72.5MCall Options Held
60.8KPut Options Held
58K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.4MShares$193 Million1.95% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.85MShares$176 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.83MShares$176 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$163 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL3.91MShares$118 Million0.41% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $1.7B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...